Berlin, Germany

Nikolay Sitnikov

This inventor holds 3 USPTO granted patents and 7 published patent applications. Top assignee: Nimbus Wadjet, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolay Sitnikov. Retrieved from https://idiyas.com/inventor/nikolay-sitnikov-s29y0xj8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Nikolay Sitnikov

Introduction

Nikolay Sitnikov is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of WRN inhibitors. With a total of two patents to his name, Sitnikov is recognized for his dedication to advancing medical science.

Latest Patents

Nikolay Sitnikov's latest patents focus on WRN inhibitors. The first patent discloses compounds of Formula I and pharmaceutically acceptable salts thereof, along with compositions and methods for treating cancers involving the WRN protein. The second patent presents compounds of Formula II-e, also including pharmaceutically acceptable salts and methods for cancer treatment related to the WRN protein. These innovations hold promise for improving therapeutic options for cancer patients.

Career Highlights

Sitnikov is currently employed at Nimbus Wadjet, Inc., where he continues to push the boundaries of cancer research. His work is characterized by a commitment to developing effective treatments that target specific cancer mechanisms. His contributions have been instrumental in the ongoing fight against cancer.

Collaborations

Nikolay collaborates with talented individuals in his field, including Derun Li and Angela V West. These partnerships enhance the research environment and foster innovative solutions in cancer treatment.

Conclusion

Nikolay Sitnikov's work exemplifies the spirit of innovation in the medical field. His patents on WRN inhibitors represent a significant step forward in cancer treatment, showcasing his dedication to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…